Sign in
4

Changes in Ownership

Tarsus Pharmaceuticals, Inc. Filed Acc 0001788542-23-000002

Chief Commercial Officer sold 697 shares at an average $12.94 ($9,016)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Mottiwala Aziz Chief Commercial Officer 2023-03-17 Sale −339 $13.28 $4,502 54,265 D
Mottiwala Aziz Chief Commercial Officer 2023-03-20 Sale −358 $12.61 $4,514 53,907 D
Open-market sales · 697 sh · avg $12.94 · $9,016
Loading xslF345X04/wf-form4_167944011481271.xml…